Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PAIN THERAPEUTICS INC | 30,000 | reported | 13 Dec 2019 | tx 15+430,000 |
| SANGAMO THERAPEUTICS, INC | 25,000 | reported | 25 Feb 2022 | tx 39+274,600−150,000 |
| Monster Digital, Inc. | 25,000 | reported | 24 Apr 2020 | tx 4+125,000 |
| Vir Biotechnology, Inc. | 16,000 | reported | 30 May 2025 | tx 22+221,580−39,187 |
| Mirum Pharmaceuticals, Inc. | 2,000 | reported | 15 May 2026 | tx 37+120,930−90,406 |
| Akouos, Inc. | 0 | reported | 01 Dec 2022 | tx 4+54,625−16,000 |
| Day One Biopharmaceuticals, Inc. | 0 | reported | 23 Apr 2026 | tx 24+322,151−460,217 |
| ZONAGEN INC | 0 | reported | 31 Jan 2018 | tx 10+95,000−45,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 2,000 | 23.51 USD | 10b5-1 |
| 15 May 2026 | SALE | Mirum Pharmaceuticals, Inc. | 2,000 | 109.47 USD | 10b5-1 |
| 15 May 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 2,000 | 0.00 USD | 10b5-1deriv |
| 23 Apr 2026 | OTHER | Day One Biopharmaceuticals, Inc. | 40,485 | — | |
| 23 Apr 2026 | OTHER | Day One Biopharmaceuticals, Inc. | 40,000 | — | deriv |
| 23 Apr 2026 | OTHER | Day One Biopharmaceuticals, Inc. | 47,581 | — | deriv |
| 23 Apr 2026 | OTHER | Day One Biopharmaceuticals, Inc. | 28,700 | — | deriv |
| 23 Apr 2026 | OTHER | Day One Biopharmaceuticals, Inc. | 37,500 | — | deriv |
| 23 Apr 2026 | OTHER | Day One Biopharmaceuticals, Inc. | 32,335 | — | deriv |
| 23 Apr 2026 | OTHER | Day One Biopharmaceuticals, Inc. | 22,500 | — | deriv |
| 23 Apr 2026 | OTHER | Day One Biopharmaceuticals, Inc. | 15,000 | — | deriv |
| 16 Mar 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 2,000 | 23.51 USD | |
| 16 Mar 2026 | SALE | Mirum Pharmaceuticals, Inc. | 2,000 | 90.76 USD | |
| 16 Mar 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 2,000 | 0.00 USD | deriv |
| 13 Feb 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 2,000 | 23.51 USD | |
| 13 Feb 2026 | SALE | Mirum Pharmaceuticals, Inc. | 2,000 | 102.09 USD | |
| 13 Feb 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 2,000 | 0.00 USD | deriv |
| 15 Jan 2026 | SALE | Mirum Pharmaceuticals, Inc. | 2,000 | 90.99 USD | |
| 15 Jan 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 2,000 | 23.51 USD | |
| 15 Jan 2026 | EXERCISE | Mirum Pharmaceuticals, Inc. | 2,000 | 0.00 USD | deriv |
| 22 Dec 2025 | SALE | Mirum Pharmaceuticals, Inc. | 5,000 | 80.00 USD | |
| 22 Dec 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 5,000 | 23.51 USD | |
| 22 Dec 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |
| 18 Dec 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 2,000 | 23.51 USD | |
| 18 Dec 2025 | SALE | Mirum Pharmaceuticals, Inc. | 1,000 | 69.46 USD |